{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:33:41Z","timestamp":1794324821499,"version":"4.9.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Veterans Affairs Research Services","award":["BX001350"],"award-info":[{"award-number":["BX001350"]}]},{"name":"National Institutes of Health,United States","award":["AI143694"],"award-info":[{"award-number":["AI143694"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI064687"],"award-info":[{"award-number":["AI064687"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI173171"],"award-info":[{"award-number":["1R01AI173171"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M021157\/1"],"award-info":[{"award-number":["MR\/M021157\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      has been more resistant to various control measures than\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      malaria because of its greater transmissibility and ability to produce latent parasite forms. Therefore, developing\n                      <jats:italic>P. vivax<\/jats:italic>\n                      vaccines and therapeutic monoclonal antibodies (humAbs) remains a high priority. The Duffy antigen receptor for chemokines (DARC) expressed on erythrocytes is central to\n                      <jats:italic>P. vivax<\/jats:italic>\n                      invasion of reticulocytes.\n                      <jats:italic>P. vivax<\/jats:italic>\n                      expresses a Duffy binding protein (PvDBP) on merozoites, a DARC ligand, and the DARC: PvDBP interaction is critical for\n                      <jats:italic>P. vivax<\/jats:italic>\n                      blood stage malaria. Therefore, PvDBP is a leading vaccine candidate for\n                      <jats:italic>P. vivax<\/jats:italic>\n                      and a target for therapeutic human monoclonal antibodies (humAbs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Here, the functional activity of humAbs derived from naturally exposed and vaccinated individuals are compared for the first time using easily cultured\n                      <jats:italic>Plasmodium knowlesi<\/jats:italic>\n                      (\n                      <jats:italic>P. knowlesi<\/jats:italic>\n                      ) that had been genetically modified to replace its endogenous PkDBP orthologue with PvDBP to create a transgenic parasite, PkPvDBPOR. This transgenic parasite requires DARC to invade human erythrocytes but is not reticulocyte restricted. This model was used to evaluate the invasion inhibition potential of 12 humAbs (9 naturally acquired; 3 vaccine-induced) targeting PvDBP individually and in combinations using growth inhibition assays (GIAs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The PvDBP-specific humAbs demonstrated 70\u2013100% inhibition of PkPvDBPOR invasion with the IC\n                      <jats:sub>50<\/jats:sub>\n                      values ranging from 51 to 338\u00a0\u00b5g\/mL for the 9 naturally acquired (NA) humAbs and 33 to 99\u00a0\u00b5g\/ml for the 3 vaccine-induced (VI) humAbs. To evaluate antagonistic, additive, or synergistic effects, six pairwise combinations were performed using select humAbs. Of these combinations tested, one NA\/NA (099100\/094083) combination demonstrated relatively strong additive inhibition between 10 and 100\u00a0\u00b5g\/mL; all combinations of NA and VI humAbs showed additive inhibition at concentrations below 25\u00a0\u00b5g\/mL and antagonism at higher concentrations. None of the humAb combinations showed synergy. Invasion inhibition efficacy by some mAbs shown with PkPvDBPOR was closely replicated using\n                      <jats:italic>P. vivax<\/jats:italic>\n                      clinical isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The PkPvDBPOR transgenic model is a robust surrogate of\n                      <jats:italic>P. vivax<\/jats:italic>\n                      to assess invasion and growth inhibition of human monoclonal Abs recognizing PvDBP individually and in combination. There was no synergistic interaction for growth inhibition with the humAbs tested here that target different epitopes or subdomains of PvDBP, suggesting little benefit in clinical trials using combinations of these humAbs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-023-04766-1","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T13:01:41Z","timestamp":1701694901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein"],"prefix":"10.1186","volume":"22","author":[{"given":"Quentin D.","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore L.","family":"Carias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Malachin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karli R.","family":"Redinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martino","family":"Bardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Baldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel Brice","family":"Feufack-Donfack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Popovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"4766_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0140-6736(19)31096-7","volume":"394","author":"KE Battle","year":"2019","unstructured":"Battle KE, Lucas TCD, Nguyen M, Howes RE, Nandi AK, Twohig KA, et al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000\u201317: a spatial and temporal modelling study. Lancet. 2019;394:332\u201343.","journal-title":"Lancet"},{"key":"4766_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12916-020-1497-0","volume":"18","author":"S Dini","year":"2020","unstructured":"Dini S, Douglas NM, Poespoprodjo JR, Kenangalem E, Sugiarto P, Plumb ID, et al. The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study. BMC Med. 2020;18:28.","journal-title":"BMC Med"},{"key":"4766_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12936-015-0884-z","volume":"14","author":"CM Moreira","year":"2015","unstructured":"Moreira CM, Abo-Shehada M, Price RN, Drakeley CJ. A systematic review of sub-microscopic Plasmodium vivax infection. Malar J. 2015;14:360.","journal-title":"Malar J"},{"key":"4766_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004222","volume":"9","author":"RE Howes","year":"2015","unstructured":"Howes RE, Reiner RC Jr, Battle KE, Longbottom J, Mappin B, Ordanovich D, et al. Plasmodium vivax transmission in Africa. PLoS Negl Trop Dis. 2015;9: e0004222.","journal-title":"PLoS Negl Trop Dis"},{"key":"4766_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007140","volume":"13","author":"KA Twohig","year":"2019","unstructured":"Twohig KA, Pfeffer DA, Baird JK, Price RN, Zimmerman PA, Hay SI, et al. Growing evidence of Plasmodium vivax across malaria-endemic Africa. PLoS Negl Trop Dis. 2019;13: e0007140.","journal-title":"PLoS Negl Trop Dis"},{"key":"4766_CR6","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4269\/ajtmh.17-0461","volume":"97","author":"PA Zimmerman","year":"2017","unstructured":"Zimmerman PA. Plasmodium vivax Infection in Duffy-Negative people in Africa. Am J Trop Med Hyg. 2017;97:636\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"4766_CR7","volume-title":"The potential impact of health service disruptions on the burden of malaria: a modelling analysis for countries in sub-Saharan Africa","author":"WHO","year":"2020","unstructured":"WHO. The potential impact of health service disruptions on the burden of malaria: a modelling analysis for countries in sub-Saharan Africa. Geneva: World Health Organization; 2020."},{"key":"4766_CR8","volume-title":"A year without precedent: WHO\u2019s COVID-19 response","author":"WHO","year":"2020","unstructured":"WHO. A year without precedent: WHO\u2019s COVID-19 response. Geneva: World Health Organization; 2020."},{"key":"4766_CR9","volume-title":"World Malaria Report 2022","author":"WHO","year":"2022","unstructured":"WHO. World Malaria Report 2022. Geneva: World Health Organization; 2022."},{"key":"4766_CR10","doi-asserted-by":"crossref","unstructured":"Bachelerie F, Ben-Baruch A, Burkhardt AM, Combadiere C, Farber JM, Graham GJ, et al. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev. 2014;66:1\u201379.","DOI":"10.1124\/pr.113.007724"},{"key":"4766_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0092-8674(90)90295-P","volume":"63","author":"JH Adams","year":"1990","unstructured":"Adams JH, Hudson DE, Torii M, Ward GE, Wellems TE, Aikawa M, et al. The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell. 1990;63:141\u201353.","journal-title":"Cell"},{"key":"4766_CR12","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1073\/pnas.89.15.7085","volume":"89","author":"JH Adams","year":"1992","unstructured":"Adams JH, Sim BK, Dolan SA, Fang X, Kaslow DC, Miller LH. A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci USA. 1992;89:7085\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/0014-4894(89)90083-0","volume":"69","author":"SP Wertheimer","year":"1989","unstructured":"Wertheimer SP, Barnwell JW. Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein. Exp Parasitol. 1989;69:340\u201350.","journal-title":"Exp Parasitol"},{"key":"4766_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003869","volume":"10","author":"JD Batchelor","year":"2014","unstructured":"Batchelor JD, Malpede BM, Omattage NS, DeKoster GT, Henzler-Wildman KA, Tolia NH. Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC. PLoS Pathog. 2014;10: e1003869.","journal-title":"PLoS Pathog"},{"key":"4766_CR15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/nsmb.2088","volume":"18","author":"JD Batchelor","year":"2011","unstructured":"Batchelor JD, Zahm JA, Tolia NH. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol. 2011;18:908\u201314.","journal-title":"Nat Struct Mol Biol"},{"key":"4766_CR16","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1084\/jem.184.4.1531","volume":"184","author":"CE Chitnis","year":"1996","unstructured":"Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J Exp Med. 1996;184:1531\u20136.","journal-title":"J Exp Med"},{"key":"4766_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1084\/jem.180.2.497","volume":"180","author":"CE Chitnis","year":"1994","unstructured":"Chitnis CE, Miller LH. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med. 1994;180:497\u2013506.","journal-title":"J Exp Med"},{"key":"4766_CR18","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.1365-2958.2005.04484.x","volume":"55","author":"D Hans","year":"2005","unstructured":"Hans D, Pattnaik P, Bhattacharyya A, Shakri AR, Yazdani SS, Sharma M, et al. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol Microbiol. 2005;55:1423\u201334.","journal-title":"Mol Microbiol"},{"key":"4766_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1475-2875-7-112","volume":"7","author":"P Gosi","year":"2008","unstructured":"Gosi P, Khusmith S, Khalambaheti T, Lanar DE, Schaecher KE, Fukuda MM, et al. Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolates. Malar J. 2008;7:112.","journal-title":"Malar J"},{"key":"4766_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0166-6851(00)00315-7","volume":"111","author":"J Xainli","year":"2000","unstructured":"Xainli J, Adams JH, King CL. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol Biochem Parasitol. 2000;111:253\u201360.","journal-title":"Mol Biochem Parasitol"},{"key":"4766_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1128\/IAI.01036-09","volume":"78","author":"P Chootong","year":"2010","unstructured":"Chootong P, Ntumngia FB, VanBuskirk KM, Xainli J, Cole-Tobian JL, Campbell CO, et al. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect Immun. 2010;78:1089\u201395.","journal-title":"Infect Immun"},{"key":"4766_CR22","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.3390\/ijms21134729","volume":"21","author":"MA Patarroyo","year":"2020","unstructured":"Patarroyo MA, Molina-Franky J, Gomez M, Arevalo-Pinzon G, Patarroyo ME. Hotspots in Plasmodium and RBC receptor-ligand interactions: key pieces for inhibiting malarial parasite invasion. Int J Mol Sci. 2020;21:4729.","journal-title":"Int J Mol Sci"},{"key":"4766_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006555","volume":"12","author":"C Roesch","year":"2018","unstructured":"Roesch C, Popovici J, Bin S, Run V, Kim S, Ramboarina S, et al. Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion. PLoS Negl Trop Dis. 2018;12: e0006555.","journal-title":"PLoS Negl Trop Dis"},{"key":"4766_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.27.22275375","author":"MM Hou","year":"2022","unstructured":"Hou MM, Barrett JR, Themistocleous Y, Rawlinson TA, Diouf A, Martinez FJ, et al. Impact of a blood-stage vaccine on Plasmodium vivax malaria. MedRxiv. 2022. https:\/\/doi.org\/10.1101\/2022.05.27.22275375.","journal-title":"MedRxiv."},{"key":"4766_CR25","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1073\/pnas.1600488113","volume":"113","author":"E Chen","year":"2016","unstructured":"Chen E, Salinas ND, Huang Y, Ntumngia F, Plasencia MD, Gross ML, et al. Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein. Proc Natl Acad Sci USA. 2016;113:6277\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1128\/IAI.05924-11","volume":"80","author":"FB Ntumngia","year":"2012","unstructured":"Ntumngia FB, Schloegel J, Barnes SJ, McHenry AM, Singh S, King CL, et al. Conserved and variant epitopes of Plasmodium vivax Duffy binding protein as targets of inhibitory monoclonal antibodies. Infect Immun. 2012;80:1203\u20138.","journal-title":"Infect Immun"},{"key":"4766_CR27","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/s41564-019-0587-2","volume":"4","author":"D Urusova","year":"2019","unstructured":"Urusova D, Carias L, Huang Y, Nicolete VC, Popovici J, Roesch C, et al. Author correction: structural basis for neutralization of Plasmodium vivax by naturally acquired human antibodies that target DBP. Nat Microbiol. 2019;4:2024.","journal-title":"Nat Microbiol"},{"key":"4766_CR28","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1073\/pnas.0800371105","volume":"105","author":"CL King","year":"2008","unstructured":"King CL, Michon P, Shakri AR, Marcotty A, Stanisic D, Zimmerman PA, et al. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci USA. 2008;105:8363\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR29","doi-asserted-by":"publisher","first-page":"e9047","DOI":"10.1371\/journal.pone.0009047","volume":"5","author":"E Lin","year":"2010","unstructured":"Lin E, Kiniboro B, Gray L, Dobbie S, Robinson L, Laumaea A, et al. Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS ONE. 2010;5:e9047.","journal-title":"PLoS ONE"},{"key":"4766_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035769","volume":"7","author":"P Chootong","year":"2012","unstructured":"Chootong P, Panichakul T, Permmongkol C, Barnes SJ, Udomsangpetch R, Adams JH. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand. PLoS ONE. 2012;7: e35769.","journal-title":"PLoS ONE"},{"key":"4766_CR31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1590\/0074-0276130592","volume":"109","author":"TN de Sousa","year":"2014","unstructured":"de Sousa TN, Kano FS, de Brito CF, Carvalho LH. The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian Amazon. Mem Inst Oswaldo Cruz. 2014;109:608\u201317.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"4766_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/infdis\/jiw407","volume":"214","author":"VC Nicolete","year":"2016","unstructured":"Nicolete VC, Frischmann S, Barbosa S, King CL, Ferreira MU. Naturally acquired binding-inhibitory antibodies to Plasmodium vivax Duffy Binding Protein and clinical immunity to malaria in rural Amazonians. J Infect Dis. 2016;214:1539\u201346.","journal-title":"J Infect Dis"},{"key":"4766_CR33","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.4049\/jimmunol.1801631","volume":"202","author":"LL Carias","year":"2019","unstructured":"Carias LL, Dechavanne S, Nicolete VC, Sreng S, Suon S, Amaratunga C, et al. Identification and characterization of functional human monoclonal antibodies to Plasmodium vivax Duffy-Binding Protein. J Immunol. 2019;202:2648\u201360.","journal-title":"J Immunol"},{"key":"4766_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93683","volume":"2","author":"RO Payne","year":"2017","unstructured":"Payne RO, Silk SE, Elias SC, Milne KH, Rawlinson TA, Llewellyn D, et al. Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies. JCI Insight. 2017;2: e93683.","journal-title":"JCI Insight"},{"key":"4766_CR35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/cmi.12275","volume":"16","author":"C Gruring","year":"2014","unstructured":"Gruring C, Moon RW, Lim C, Holder AA, Blackman MJ, Duraisingh MT. Human red blood cell-adapted Plasmodium knowlesi parasites: a new model system for malaria research. Cell Microbiol. 2014;16:612\u201320.","journal-title":"Cell Microbiol"},{"key":"4766_CR36","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3522","volume":"10","author":"F Mohring","year":"2020","unstructured":"Mohring F, Hart MN, Patel A, Baker DA, Moon RW. CRISPR-Cas9 genome editing of Plasmodium knowlesi. Bio Protoc. 2020;10: e3522.","journal-title":"Bio Protoc"},{"key":"4766_CR37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1073\/pnas.1216457110","volume":"110","author":"RW Moon","year":"2013","unstructured":"Moon RW, Hall J, Rangkuti F, Ho YS, Almond N, Mitchell GH, et al. Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes. Proc Natl Acad Sci USA. 2013;110:531\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR38","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/s41564-019-0462-1","volume":"4","author":"TA Rawlinson","year":"2019","unstructured":"Rawlinson TA, Barber NM, Mohring F, Cho JS, Kosaisavee V, Gerard SF, et al. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody. Nat Microbiol. 2019;4:1497\u2013507.","journal-title":"Nat Microbiol"},{"key":"4766_CR39","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1073\/pnas.0912496107","volume":"107","author":"D Menard","year":"2010","unstructured":"Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, et al. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA. 2010;107:5967\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4766_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","volume":"329","author":"T Tiller","year":"2008","unstructured":"Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods. 2008;329:112\u201324.","journal-title":"J Immunol Methods"},{"key":"4766_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-62703-269-8_5","volume":"971","author":"H Wardemann","year":"2013","unstructured":"Wardemann H, Kofer J. Expression cloning of human B cell immunoglobulins. Methods Mol Biol. 2013;971:93\u2013111.","journal-title":"Methods Mol Biol"},{"key":"4766_CR42","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1007\/s00018-010-0387-6","volume":"67","author":"D Smolarek","year":"2010","unstructured":"Smolarek D, Hattab C, Hassanzadeh-Ghassabeh G, Cochet S, Gutierrez C, de Brevern AG, et al. A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines. Cell Mol Life Sci. 2010;67:3371\u201387.","journal-title":"Cell Mol Life Sci"},{"key":"4766_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0003-2697(82)90041-0","volume":"124","author":"TC Ford","year":"1982","unstructured":"Ford TC, Rickwood D. Formation of isotonic Nycodenz gradients for cell separations. Anal Biochem. 1982;124:293\u20138.","journal-title":"Anal Biochem"},{"key":"4766_CR44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41467-020-14574-9","volume":"11","author":"J Popovici","year":"2020","unstructured":"Popovici J, Roesch C, Carias LL, Khim N, Kim S, Vantaux A, et al. Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunity. Nat Commun. 2020;11:953.","journal-title":"Nat Commun"},{"key":"4766_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02519-17","author":"GW Rangel","year":"2018","unstructured":"Rangel GW, Clark MA, Kanjee U, Lim C, Shaw-Saliba K, Menezes MJ, et al. Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assays. Antimicrob Agents Chemother. 2018. https:\/\/doi.org\/10.1128\/AAC.02519-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"W1","key":"4766_CR46","doi-asserted-by":"publisher","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","volume":"48","author":"A Ianevski","year":"2020","unstructured":"Ianevski A, Giri AK, Aittokallio T. SynergyFinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 2020;48(W1):W488\u201393.","journal-title":"Nucleic Acids Res"},{"key":"4766_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","volume":"561","author":"P Mendoza","year":"2018","unstructured":"Mendoza P, Gruell H, Nogueira L, Pai JA, Butler AL, Millard K, et al. Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018;561:479\u201384.","journal-title":"Nature"},{"key":"4766_CR48","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","volume":"381","author":"S Mulangu","year":"2019","unstructured":"Mulangu S, Dodd LE, Davey RT, Tshiani Mbaya O, Proschan M, Mukadi D, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med. 2019;381:2293\u2013303.","journal-title":"N Engl J Med"},{"key":"4766_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1056\/NEJMoa2035002","volume":"384","author":"DM Weinreich","year":"2021","unstructured":"Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021;384:238\u201351.","journal-title":"N Engl J Med"},{"key":"4766_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41541-018-0083-3","volume":"3","author":"K Singh","year":"2018","unstructured":"Singh K, Mukherjee P, Shakri AR, Singh A, Pandey G, Bakshi M, et al. Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial. NPJ Vaccines. 2018;3:48.","journal-title":"NPJ Vaccines"},{"key":"4766_CR51","doi-asserted-by":"publisher","first-page":"eadf1782","DOI":"10.1126\/scitranslmed.adf1782","volume":"15","author":"MM Hou","year":"2023","unstructured":"Hou MM, Barrett JR, Themistocleous Y, Rawlinson TA, Diouf A, Martinez FJ, et al. Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection. Sci Transl Med. 2023;15:eadf1782.","journal-title":"Sci Transl Med."},{"key":"4766_CR52","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.immuni.2020.08.014","volume":"53","author":"LT Wang","year":"2020","unstructured":"Wang LT, Pereira LS, Flores-Garcia Y, O\u2019Connor J, Flynn BJ, Sch\u00f6n A, et al. A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver. Immunity. 2020;53:733-44.e8.","journal-title":"Immunity"},{"key":"4766_CR53","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm.4512","volume":"24","author":"NK Kisalu","year":"2018","unstructured":"Kisalu NK, Idris AH, Weidle C, Flores-Garcia Y, Flynn BJ, Sack BK, et al. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite. Nat Med. 2018;24:408\u201316.","journal-title":"Nat Med"},{"key":"4766_CR54","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","volume":"387","author":"K Kayentao","year":"2022","unstructured":"Kayentao K, Ongoiba A, Preston AC, Healy SA, Doumbo S, Doumtabe D, et al. Safety and efficacy of a monoclonal antibody against malaria in Mali. N Engl J Med. 2022;387:1833\u201342.","journal-title":"N Engl J Med"},{"key":"4766_CR55","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa2034031","volume":"385","author":"MR Gaudinski","year":"2021","unstructured":"Gaudinski MR, Berkowitz NM, Idris AH, Coates EE, Holman LA, Mendoza F, et al. A monoclonal antibody for malaria prevention. N Engl J Med. 2021;385:803\u201314.","journal-title":"N Engl J Med"},{"key":"4766_CR56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220367","author":"M Agudelo","year":"2022","unstructured":"Agudelo M, Muecksch F, Schaefer-Babajew D, Cho A, DaSilva J, Bednarski E, et al. Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants. J Exp Med. 2022. https:\/\/doi.org\/10.1084\/jem.20220367.","journal-title":"J Exp Med"},{"key":"4766_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.virol.2011.09.019","volume":"422","author":"TJ Ketas","year":"2012","unstructured":"Ketas TJ, Holuigue S, Matthews K, Moore JP, Klasse PJ. Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors. Virology. 2012;422:22\u201336.","journal-title":"Virology"},{"key":"4766_CR58","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nature01188","volume":"420","author":"PD Kwong","year":"2002","unstructured":"Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature. 2002;420:678\u201382.","journal-title":"Nature"},{"key":"4766_CR59","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.virol.2014.11.011","volume":"475","author":"KP Ramirez Valdez","year":"2015","unstructured":"Ramirez Valdez KP, Kuwata T, Maruta Y, Tanaka K, Alam M, Yoshimura K, et al. Complementary and synergistic activities of anti-V3, CD4bs and CD4i antibodies derived from a single individual can cover a wide range of HIV-1 strains. Virology. 2015;475:187\u2013203.","journal-title":"Virology"},{"key":"4766_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009688","volume":"17","author":"KKA Van Rompay","year":"2021","unstructured":"Van Rompay KKA, Olstad KJ, Sammak RL, Dutra J, Watanabe JK, Usachenko JL, et al. Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques. PLoS Pathog. 2021;17: e1009688.","journal-title":"PLoS Pathog"},{"key":"4766_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010133","volume":"17","author":"LT Wang","year":"2021","unstructured":"Wang LT, Pereira LS, Kiyuka PK, Schon A, Kisalu NK, Vistein R, et al. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein. PLoS Pathog. 2021;17: e1010133.","journal-title":"PLoS Pathog"},{"key":"4766_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100326","volume":"2","author":"AC Willcox","year":"2021","unstructured":"Willcox AC, Huber AS, Diouf A, Barrett JR, Silk SE, Pulido D, et al. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies. Cell Rep Med. 2021;2: 100326.","journal-title":"Cell Rep Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-023-04766-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04766-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T14:02:53Z","timestamp":1701698573000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-023-04766-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4766"],"URL":"https:\/\/doi.org\/10.1186\/s12936-023-04766-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies followed protocols approved by the University Hospitals of Cleveland Institutional Review Board (#08-03-33 and #09-90-195). Use of the clinical isolates was approved by the Cambodian National Ethics Committee for Health Research (192 NECR, July 11th, 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}